Literature DB >> 25682900

MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase.

Jenni Heidi Eveliina Mäki-Jouppila1, Sofia Pruikkonen2, Mahesh Balasaheb Tambe3, Miriam Ragle Aure4, Tuuli Halonen5, Anna-Leena Salmela5, Leena Laine6, Anne-Lise Børresen-Dale7, Marko Johannes Kallio8.   

Abstract

The let-7 microRNA (miRNA) family has been implicated in the regulation of diverse cellular processes and disease pathogenesis. In cancer, loss-of-function of let-7 miRNAs has been linked to tumorigenesis via increased expression of target oncogenes. Excessive proliferation rate of tumor cells is often associated with deregulation of mitotic proteins. Here, we show that let-7b contributes to the maintenance of genomic balance via targeting Aurora B kinase, a key regulator of the spindle assembly checkpoint (SAC). Our results indicate that let-7b binds to Aurora B kinase 3'UTR reducing mRNA and protein expression of the kinase. In cells, excess let-7b induced mitotic defects characteristic to Aurora B perturbation including increased rate of polyploidy and multipolarity, and premature SAC inactivation that leads to forced exit from chemically induced mitotic arrest. Moreover, the frequency of aneuploid HCT-116 cells was significantly increased upon let-7b overexpression compared to controls. Interestingly, together with a chemical Aurora B inhibitor, let-7b had an additive effect on polyploidy induction in HeLa cells. In breast cancer patients, reduced let-7b expression was found to be associated with increased Aurora B expression in grade 3 tumors. Furthermore, let-7b was found downregulated in the most aggressive forms of breast cancer determined by clinicopathological parameters. Together, our findings suggest that let-7b contributes to the fidelity of cell division via regulation of Aurora B. Moreover, the loss of let-7b in aggressive tumors may drive tumorigenesis by up-regulation of Aurora B and other targets of the miRNA, which further supports the role of let-7b in tumor suppression.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aneuploidy; Aurora B; Let-7b; MicroRNA; Mitosis

Mesh:

Substances:

Year:  2015        PMID: 25682900      PMCID: PMC5528760          DOI: 10.1016/j.molonc.2015.01.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  51 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.

Authors:  B Naume; E Borgen; G Kvalheim; R Kåresen; H Qvist; T Sauer; T Kumar; J M Nesland
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

6.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

Authors:  Scott L Carter; Aron C Eklund; Isaac S Kohane; Lyndsay N Harris; Zoltan Szallasi
Journal:  Nat Genet       Date:  2006-08-20       Impact factor: 38.330

7.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer.

Authors:  Aurora Esquela-Kerscher; Phong Trang; Jason F Wiggins; Lubna Patrawala; Angie Cheng; Lance Ford; Joanne B Weidhaas; David Brown; Andreas G Bader; Frank J Slack
Journal:  Cell Cycle       Date:  2008-03-03       Impact factor: 4.534

8.  Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.

Authors:  Bjørn Naume; Xi Zhao; Marit Synnestvedt; Elin Borgen; Hege Giercksky Russnes; Ole Christian Lingjaerde; Maria Strømberg; Gro Wiedswang; Gunnar Kvalheim; Rolf Kåresen; Jahn M Nesland; Anne-Lise Børresen-Dale; Therese Sørlie
Journal:  Mol Oncol       Date:  2007-04-04       Impact factor: 6.603

9.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

10.  The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.

Authors:  Xiao-Yan He; Jun-xia Chen; Zheng Zhang; Chun-lei Li; Qiong-le Peng; Hui-min Peng
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-22       Impact factor: 4.553

View more
  11 in total

Review 1.  Dissecting the mechanisms of cell division.

Authors:  Joseph Y Ong; Jorge Z Torres
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

2.  The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).

Authors:  Ali Zekri; Yashar Mesbahi; Elham Boustanipour; Zahra Sadr; Seyed H Ghaffari
Journal:  J Mol Neurosci       Date:  2018-07-26       Impact factor: 3.444

Review 3.  miRNA dysregulation is an emerging modulator of genomic instability.

Authors:  Ana P Ferragut Cardoso; Mayukh Banerjee; Alexandra N Nail; Angeliki Lykoudi; J Christopher States
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

4.  Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity.

Authors:  Sofia Pruikkonen; Marko J Kallio
Journal:  Br J Cancer       Date:  2017-04-27       Impact factor: 7.640

5.  Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.

Authors:  Jing-Jing Yu; Wen-Sen Pi; Yuan Cao; Ai-Fen Peng; Zhi-Yuan Cao; Jia-Ming Liu; Shan-Hu Huang; Zhi-Li Liu; Wei Zhang
Journal:  Cancer Manag Res       Date:  2018-11-26       Impact factor: 3.989

6.  E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity.

Authors:  Jie-Ning Li; Hui-Lung Sun; Ming-Yang Wang; Pai-Sheng Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-05

7.  Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.

Authors:  Mahesh Tambe; Sofia Pruikkonen; Jenni Mäki-Jouppila; Ping Chen; Bente Vilming Elgaaen; Anne Hege Straume; Kaisa Huhtinen; Olli Cárpen; Per Eystein Lønning; Ben Davidson; Sampsa Hautaniemi; Marko J Kallio
Journal:  Oncotarget       Date:  2016-03-15

8.  MicroRNA profiles involved in trifluridine resistance.

Authors:  Kenta Tsunekuni; Masamitsu Konno; Ayumu Asai; Jun Koseki; Takashi Kobunai; Teiji Takechi; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Oncotarget       Date:  2017-05-23

9.  MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells.

Authors:  Sofia Aakko; Anne Hege Straume; Einar Elvbakken Birkeland; Ping Chen; Xi Qiao; Per Eystein' 'Lønning; Marko J Kallio
Journal:  Transl Oncol       Date:  2018-10-22       Impact factor: 4.243

10.  Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression).

Authors:  Zhenlin Ju; Anjana Bhardwaj; Matthew D Embury; Harpreet Singh; Preethi H Gunaratne; Isabelle Bedrosian; Jing Wang
Journal:  Cancers (Basel)       Date:  2020-03-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.